Simplified methods for obtaining purified oocysts from mice and for growing Cryptosporidium parvum in vitro

被引:84
作者
Meloni, BP
Thompson, RCA
机构
[1] WHO Collaborating Ctr. Molec. E., School of Veterinary Studies, Murdoch University, Murdoch
关键词
D O I
10.2307/3283888
中图分类号
R38 [医学寄生虫学]; Q [生物科学];
学科分类号
07 ; 0710 ; 09 ; 100103 ;
摘要
Seven- to 8-day-old Arc/Swiss mice were infected with 100,000-120,000 Cryptosporidium parvum oocysts. At 8 days postinfection (PI) the jejunum, ileum, cecum, colon, and rectum were removed. Using a simple extraction procedure and purification by Ficoll gradient centrifugation, we rountinely obtained between 3-6 million and up to 15 million purified oocysts per mouse. For in vitro cultivation, purified oocysts were pretreated in a tow pH (2.5-3) 0.5% trypsin solution for 20 min, resuspended in supplemented RPMI-1640 containing glucose 0.1 g (5.55 mM), sodium bicarbonate 0.3 g, bovine bile 0.02 g, folic acid 25 mu g, 4-aminobenzoic acid 100 mu g, calcium pantothenate 50 mu g, ascorbic acid 875 mu g, penicillin G 10,000 U and streptomycin 0.01 g per 100 ml, and 1% fetal bovine serum (pH 7.4 before filtration), and used to inoculate confluent monolayers of the human adenocarcinoma cell line HCT-8. Incubation was in a candle jar at 37 C. We tested numerous supplements to RPMI-1640, different pHs, and atmospheric conditions and found the parameters described above produced the greatest parasite numbers in vitro. We obtained significantly superior growth of C. parvum grown in HCT-8 cells using the conditions described above than in culture conditions described previously.
引用
收藏
页码:757 / 762
页数:6
相关论文
共 37 条
[1]  
Angus K.W., 1990, P83
[2]   PROPHYLACTIC EFFECTS OF ANTICOCCIDIAL DRUGS IN EXPERIMENTAL MURINE CRYPTOSPORIDIOSIS [J].
ANGUS, KW ;
HUTCHISON, G ;
CAMPBELL, I ;
SNODGRASS, DR .
VETERINARY RECORD, 1984, 114 (07) :166-168
[3]   INHIBITION OF CRYPTOSPORIDIUM-PARVUM IN NEONATAL HSD-(ICR)BR SWISS MICE BY POLYETHER IONOPHORES AND AROMATIC AMIDINES [J].
BLAGBURN, BL ;
SUNDERMANN, CA ;
LINDSAY, DS ;
HALL, JE ;
TIDWELL, RR .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (07) :1520-1523
[4]   EPIDEMIOLOGIC ASPECTS OF HUMAN CRYPTOSPORIDIOSIS [J].
CASEMORE, DP .
EPIDEMIOLOGY AND INFECTION, 1990, 104 (01) :1-28
[5]  
Current W.L., 1990, P31
[6]  
Current W. L., 1989, Parasitic infections in the compromised host., P281
[7]   HUMAN CRYPTOSPORIDIOSIS IN IMMUNOCOMPETENT AND IMMUNODEFICIENT PERSONS - STUDIES OF AN OUTBREAK AND EXPERIMENTAL TRANSMISSION [J].
CURRENT, WL ;
REESE, NC ;
ERNST, JV ;
BAILEY, WS ;
HEYMAN, MB ;
WEINSTEIN, WM .
NEW ENGLAND JOURNAL OF MEDICINE, 1983, 308 (21) :1252-1257
[8]   COMPLETE DEVELOPMENT OF CRYPTOSPORIDIUM IN CELL-CULTURE [J].
CURRENT, WL ;
HAYNES, TB .
SCIENCE, 1984, 224 (4649) :603-605
[9]   A COMPARISON OF ENDOGENOUS DEVELOPMENT OF 3 ISOLATES OF CRYPTOSPORIDIUM IN SUCKLING MICE [J].
CURRENT, WL ;
REESE, NC .
JOURNAL OF PROTOZOOLOGY, 1986, 33 (01) :98-108
[10]  
EGGLESTON MT, 1994, J HELMINTHOL SOC W, V61, P122